Pharmacies need to get semaglutide from an FDA-registered source in order to compound it. But if its sole manufacturer isn't cooperating, doctors have major questions about where it's being sourced.

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

It seemed simple enough: She was charged a subscription fee and a fee for the medication she ordered, semaglutide, which is basically generic Ozempic. She quickly noticed her food cravings and ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is joining the fight.

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

The FDA will take action against those continuing to compound these medications after ... officially determined that the shortage of both semaglutide and tirzepatide injection products is now ...

Semaglutide is the active ingredient in Wegovy It is also the main component of Ozempic Semaglutide is known to increase the risk of hair loss Semaglutide, the main ingredient in Ozempic and ...

Now, as the battle with compound GLP-1s comes to an end ... The FDA declared last month that the shortage of semaglutide, the active ingredient for Novo’s Wegovy and Ozempic, has been resolved ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide ... definitely took advantage of this market to compound products,” said Veronica Vernon, an sssistant ...

The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for ...